A Mechanistic and Preclinical Assessment of BioRestore Bioactive Glass as a Synthetic Bone Graft Extender and Substitute for Osteoinduction and Spine Fusion

Preclinical animal study. Evaluate the osteoinductivity and bone regenerative capacity of BioRestore bioactive glass. BioRestore is a Food and Drug Administration (FDA)-approved bone void filler that has not yet been evaluated as a bone graft extender or substitute for spine fusion. In vitro and in...

Full description

Bibliographic Details

Published in:	Clinical spine surgery Vol. 37; no. 7; pp. 315 - 321
Main Authors:	Fred, Elianna J, Minardi, Silvia, Goodwin, Alyssa M, Nandurkar, Tejas S, Plantz, Mark A, Lyons, Joseph G, Paul, Jonathan T, Foley, James P, Wintring, Allison J, Furman, Andrew A, Jeong, Soyeon, Yun, Chawon, Stock, Stuart R, Hsu, Wellington K, Hsu, Erin L
Format:	Journal Article
Language:	English
Published:	United States 01-08-2024
Subjects:	Animals Biocompatible Materials - pharmacology Bone Substitutes - pharmacology Bone Transplantation Female Glass - chemistry Humans Osteogenesis - drug effects Rats Rats, Inbred F344 Spinal Fusion - methods
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!